# The Effects of Sedatives on Tobacco Use Disorder

> **NCT03813121** · PHASE1,PHASE2 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 10 (actual)

## Conditions studied

- Tobacco Use Disorder

## Interventions

- **DRUG:** midazolam intravenous infusion
- **DRUG:** placebo intravenous infusion
- **DRUG:** ketamine intravenous infusion

## Key facts

- **NCT ID:** NCT03813121
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-01
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-08-31
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03813121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03813121, "The Effects of Sedatives on Tobacco Use Disorder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03813121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*